It was found that JMJD6 could bind to the p19ARF promoter and inhibited its mRNA and protein through H4R3me2a demethylation, thereby downregulating p53 levels and blocking c-Myc-induced apoptosis of breast cancer cells (32). Here, JMJD6 is linked to breast cancer.